Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-1506-2025

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System. Recall

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.

FDA recall Class II

Ongoing

FDA lists this Class II recall for A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-1506-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jan 9, 2025
FDA report date
Apr 9, 2025
Quantity in commerce
4365 units
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

A820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.

Affected model & UDI checker

Search the exact identifiers published for Z-1506-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedA820 myPTM Software Application associated with Medtronic SynchroMed Pump and Infusion System.Check source notice00763000632793
FDA code information

version v.2x, UDI/DI 00763000632793

View the original FDA recall notice

Why was this product recalled?

Product complaints were received describing the A820 myPTM app taking longer than expected for patients to interact with their implantable pump.

What actions did Medtronic Neuromodulation take?

Medtronic issued an URGENT: MEDICAL DEVICE correction notice to its consignees on 02/28/2025 via email or US mail. The notice explained the issue and provided recommendations to temporarily mitigate the problem, and requested the following: Actions " Share this notice with all those who need to be aware of this issue within your organization and maintain a copy of this notice in your records. " Please provide a copy of the attached patient letter to your affected patients. " Please complete and return the Customer Confirmation Form enclosed with this letter, acknowledging that you have received this information. The form may be emailed to neuro.quality@medtronic.com. For questions regarding this communication, please contact Medtronic Technical Services at 1-800-707-0933 or your local Medtronic representative.

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology